Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Effect Of Recombinant Human Soluble Thrombomodulin On Clinical Outcomes Of patients With Coagulopathy After Hematopoietic Stem Cell Transplantation

SungGi Chi, Takayuki Ikezoe, MD. PhD, Asako Takeuchi, Kazuki Anabuki, Tsukie Kim, Mizu Sakai, Ayuko Taniguchi, Kazuto Togitani, Akihito Yokoyama

Blood (2013) 122 (21): 4803.

https://doi.org/10.1182/blood.V122.21.4803.4803

Published: 2013

Journal Articles

Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation.

Takayuki Ikezoe, Asako Takeuchi, Tsukie Kim, Kazuki Akabuki, Mizu Sakai, Ayuko Taniguchi, Tazuto Togitani, Akihito Yokoyama

Blood (2012) 120 (21): 2226.

https://doi.org/10.1182/blood.V120.21.2226.2226

Published: 2012

Journal Articles

Recombinant Human Soluble Thrombomodulin Enhances the Anti-Fibrinolytic and Anti-Leukemia Effects of All- Trans Retinoic Acid In Acute Promyelocytic Leukemia Cells.

Takayuki Ikezoe, Jing Yang, Chie Nishioka, Mayuka Isaka, Naomi Iwabu, Mizu Sakai, Ayuko Taniguchi, Kazuto Togitani, Goichi Honda, Akihito Yokoyama

Blood (2010) 116 (21): 1079.

https://doi.org/10.1182/blood.V116.21.1079.1079

Published: 2010

Journal Articles

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka, Ayuko Taniguchi, Yoshio Kuwayama, Naoki Komatsu, Kentaro Bandobashi, Kazuto Togitani, H. Phillip Koeffler, Hirokuni Taguchi, Akihito Yokoyama

Blood (2007) 110 (6): 2034–2040.

https://doi.org/10.1182/blood-2007-02-073700

Published: 2007

Journal Articles

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Takayuki Ikezoe, MD, Chie Nishioka, Taizo Tasaka, MD, Ayuko Taniguchi, MD, Naoki Komatsu, MD, Yoshio Kuwayama, MD, Kazuto Togitani, MD, H. Phillip Koeffler, MD, Hirokuni Taguchi, MD

Blood (2006) 108 (11): 1990.

https://doi.org/10.1182/blood.V108.11.1990.1990

Published: 2006

NARROW

Effect Of Recombinant Human Soluble Thrombomodulin On Clinical Outcomes Of patients With Coagulopathy After Hematopoietic Stem Cell Transplantation

Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation.

Recombinant Human Soluble Thrombomodulin Enhances the Anti-Fibrinolytic and Anti-Leukemia Effects of All- Trans Retinoic Acid In Acute Promyelocytic Leukemia Cells.

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Effect Of Recombinant Human Soluble Thrombomodulin On Clinical Outcomes Of patients With Coagulopathy After Hematopoietic Stem Cell Transplantation

Recombinant Human Soluble Thrombomodulin Safely and Effectively Rescues Acute Promyelocytic Leukemia Patients From Disseminated Intravascular Coagulation.

Recombinant Human Soluble Thrombomodulin Enhances the Anti-Fibrinolytic and Anti-Leukemia Effects of All- Trans Retinoic Acid In Acute Promyelocytic Leukemia Cells.

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

ZM447439, a Novel Aurora Kinase Inhibitor, Induces Growth Arrest and Apoptosis of Human Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only